Indegene Limited Completes Asset Purchase Agreement
Indegene Limited announced on April 1, 2026, that Indegene Healthcare UK Limited (Buyer) signed a Trade and Asset Purchase Agreement with Trilogy Writing & Consulting Limited (Seller). The agreement involves the purchase of the trade and Business (comprising the Assets) as a going concern.According to an intimation filed on March 1, 2026, the Buyer purchased the entire issued share capital of the Seller. Both entities are under the same group of companies and are indirectly wholly owned by Indegene Limited.
The transaction value is GBP 190,679 and is considered a related party transaction carried out at arm’s length.
Here's a summary of the key details:
| Sr. No. | Particulars | Description |
|---|---|---|
| 1 | Name(s) of parties with whom the agreement is entered | Trilogy Writing & Consulting Limited (Seller) And Indegene Healthcare UK Ltd (Buyer) |
| 2 | Purpose of entering into the agreement; | The Seller has agreed to sell and the Buyer has agreed to purchase the trade and Business (comprising the Assets) as a going concern on the terms of the agreement. |
| 3 | Size of agreement | GBP 1,90,679 |
| 4 | Shareholding, if any, in the entity with whom the agreement is executed; | 100% |
| 6 | Whether the said parties are related to promoter/promoter group/ group companies in any manner. If yes, nature of relationship | The Buyer purchased the entire issued share capital of the Seller as per our intimation filed on 1 March 2026. Both the Seller and the Buyer are under the same group of companies and are both indirectly wholly owned by Indegene Limited. |
| 7 | Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length"; | The transaction falls within related party transaction and is carried on at arm's length basis . |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.